EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline

Siwei Liu iD, Xiao Luo iD, Joanna Su Xian Chong iD, Yeerfan Jiaerken, Shim Hee Youn, Minming Zhang iD, Juan Helen Zhou iD, Alzheimer's Disease Neuroimaging Initiative

Human Brain Mapping · 2024

DOI: 10.1002/hbm.26765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Brain Mapping, 2024. Verfasst von Siwei Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Sleep and Cognition, Centre for Translational Magnetic Resonance Research, Yong Loo Lin School of Medicine, National University of Singapo…. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Disease Progression, Magnetic Resonance Imaging, Positron-Emission Tomography. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Yong Loo Lin School of Medicine Research Core Funding (National University of Singapore, Singapore), Research, Innovation and Enterprise (RIE) 2020 Advanced Manufacturing and Engineering (AME) Programmatic Fund (Agency for Science, Technology and Research (A*S…, National Medical Research Council, Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a potential preclinical stage of Alzheimer's dementia, subjective cognitive decline (SCD) reveals a higher risk of future cognitive decline and conversion to dementia. However, it has not been clear whether SCD status increases the clinical progression of older adults in the context of amyloid deposition, cerebrovascular disease (CeVD), and psychiatric symptoms. We identified 99 normal controls (NC), 15 SCD individuals who developed mild cognitive impairment in the next 2 years (P‐SCD), and 54 SCD individuals who did not (S‐SCD) from ADNI database with both baseline and 2‐year follow‐up data. Total white matter hyperintensity (WMH), WMH in deep (DWMH) and periventricular (PWMH) regions, and voxel‐wise grey matter volumes were compared among groups. Furthermore, using structural equation modelling method, we constructed path models to explore SCD‐related brain changes longitudinally and to determine whether baseline SCD status, age, and depressive symptoms affect participants' clinical outcomes. Both SCD groups showed higher baseline amyloid PET SUVR, baseline PWMH volumes, and larger increase of PWMH volumes over time than NC. In contrast, only P‐SCD had higher baseline DWMH volumes and larger increase of DWMH volumes over time than NC. No longitudinal differences in grey matter volume and amyloid was observed among NC, S‐SCD, and P‐SCD. Our path models demonstrated that SCD status contributed to future WMH progression. Further, baseline SCD status increases the risk of future cognitive decline, mediated by PWMH; baseline depressive symptoms directly contribute to clinical outcomes. In conclusion, both S‐SCD and P‐SCD exhibited more severe CeVD than NC. The CeVD burden increase was more pronounced in P‐SCD. In contrast with the direct association of depressive symptoms with dementia severity progression, the effects of SCD status on future cognitive decline may manifest via CeVD pathologies. Our work highlights the importance of multi‐modal longitudinal designs in understanding the SCD trajectory heterogeneity, paving the way for stratification and early intervention in the preclinical stage. Practitioner Points Both S‐SCD and P‐SCD exhibited more severe CeVD at baseline and a larger increase of CeVD burden compared to NC, while the burden was more pronounced in P‐SCD. Baseline SCD status increases the risk of future PWMH and DWMH volume accumulation, mediated by baseline PWMH and DWMH volumes, respectively. Baseline SCD status increases the risk of future cognitive decline, mediated by baseline PWMH, while baseline depression status directly contributes to clinical outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionDisease ProgressionMagnetic Resonance ImagingPositron-Emission TomographyHumansFemaleMaleAgedGray MatterAged, 80 and overBrainWhite MatterLongitudinal StudiesDiagnostic Self EvaluationDepression

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid depositiondepressionsubjective cognitive declinewhite matter hyperintensities

Autor:innen und Institutionen

  • Centre for Sleep and Cognition, Centre for Translational Magnetic Resonance Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Human Potential Translational Research Program, Department of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Radiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Electrical and Computer Engineering, Integrative Sciences and Engineering Programme (ISEP), NUS Graduate School, National University of Singapore, Singapore, Singapore.

ORCID-Profile: Siwei Liu, Xiao Luo, Joanna Su Xian Chong, Minming Zhang, Juan Helen Zhou

Förderung

  • Yong Loo Lin School of Medicine Research Core Funding (National University of Singapore, Singapore)
  • Research, Innovation and Enterprise (RIE) 2020 Advanced Manufacturing and Engineering (AME) Programmatic Fund (Agency for Science, Technology and Research (A*S…
  • National Medical Research Council, Singapore
  • DoD Alzheimer's Disease Neuroimaging Initiative (Department of Defense)
  • National Natural Science Foundation of China
  • Zhejiang Provincial Administration of Traditional Chinese Medicine - Youth Talent Fund Project
  • Ministry of Education, Singapore
  • NIA NIH HHS

Zitieren

APA

Liu, S., Luo, X., Chong, J. S. X., Jiaerken, Y., Youn, S. H., Zhang, M., Zhou, J. H., & Alzheimer's Disease Neuroimaging Initiative (2024). Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline. Human Brain Mapping. https://doi.org/10.1002/hbm.26765

Vancouver

Liu S, Luo X, Chong JSX, Jiaerken Y, Youn SH, Zhang M, et al. Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline. Human Brain Mapping. 2024. doi:10.1002/hbm.26765

BibTeX
@article{Liu2024,
  author = {Liu, Siwei and Luo, Xiao and Chong, Joanna Su Xian and Jiaerken, Yeerfan and Youn, Shim Hee and Zhang, Minming and Zhou, Juan Helen and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
  title = {Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline},
  journal = {Human Brain Mapping},
  year = {2024},
  doi = {10.1002/hbm.26765}
}
Kostenlos starten →